© 2017 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Sovaldi

Sovaldi-Based Hep C Regimens Safe, Effective for Those With Chronic Kidney Disease

Those with stage 3 CKD saw their kidney function improve after treatment with various combo regimens, including Harvoni.

Cirrhosis Is Linked With Hep C Treatment Failure Among Those Who Also Have HIV

Researchers identified this association after looking at real-world data on a large group of German individuals with HIV and hep C.

Hepatitis C Treatment for Teens and Children

The FDA has expanded approval of the direct-acting antiviral treatments Sovaldi and Harvoni for adolescents ages 12 and older.

Generic Hepatitis, HIV and TB Treatments Could Plunge to $90 Each

Such generic drugs could save nations huge sums in the coming years.

FDA OKs AbbVie’s Mavyret for All Hepatitis C Genotypes

The two-drug regimen can cure the virus in as little as eight weeks.

Hep C Treatment Options for Those With Chronic Kidney Disease Are Looking Up

A promising new regimen that will address unmet needs for this population is poised for FDA approval.

FDA Approves Gilead’s Vosevi for Re-treatment of Hepatitis C

The triple-drug regimen comes in a once-daily single tablet.

Hep C Treatment Success for Injection Drug Users

Forty-five IDUs who frequented a New York City syringe exchange program were recruited for HCV treatment by researchers.
Peter McLoyd and Kathy Jacobs-McLoyd

Success Through Perseverance

Hepatitis C advocate Peter McLoyd transformed his bad times into good ones.

My child has hepatitis C. The treatment for it is peginterferon and ribavirin, which have many side effects. Are there other choices?

A look at the latest hepatitis C treatment for children and teens.

Gilead’s Harvoni Boasts Near-Perfect Hepatitis Cure Rates Among Young Children

The single-tablet regimen was just approved for adolsecent pediatric use in the United States.

Generic Versions of Major Hepatitis C Drugs Prove Highly Effective

Some countries, such as Australia and the United Kingdom, permit people to import generic drugs for personal use.

FDA Approves Hepatitis C Treatment Breakthrough for Children

The FDA approved hepatitis C drugs Sovaldi and Harvoni to treat children ages 12 to 17

Harvoni

Gilead Hepatitis C Drug Patent Faces a New Challenge in Europe

If successful, the attempt could make cheaper generic versions of sofosbuvir (Sovaldi) available across the continent.

Hepatitis C Treatment and Risk of Hepatitis B Reactivation

FDA warns of risk of hepatitis B virus reactivation in patients coinfected with hepatitis C virus and hepatitis B virus.
Advertisement